These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1642672)

  • 1. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 5th communication: isolation and identification of metabolites of imidapril in rats, dogs, and monkeys.
    Yamada Y; Ohashi R; Sugawara Y; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):490-8. PubMed ID: 1642672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 7th communication: in vitro metabolism.
    Yamada Y; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):507-12. PubMed ID: 1642674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 2nd communication: tissue distribution and whole-body autoradiography of imidapril in rats.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):466-74. PubMed ID: 1642669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 3rd communication: tissue accumulation after consecutive oral administration of [N-methyl-14C]-imidapril in rats.
    Yamada Y; Endo M; Kohno M; Suzuki T; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):475-82. PubMed ID: 1642670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 4th communication: placental transfer and secretion into milk in rats.
    Endo M; Yamada Y; Kohno M; Suzuki T; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):483-9. PubMed ID: 1642671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs.
    Nishiyama S; Kanno K; Yoneda H; Yano K; Yamaguchi I
    Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new angiotensin-I-converting enzyme inhibitor imidapril on the responses of isolated vascular preparations to various agonists.
    Kubo M; Fujitsuka T; Ishida R
    Arzneimittelforschung; 1992 Apr; 42(4):446-51. PubMed ID: 1642667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and metabolism of the angiotensin-converting enzyme inhibitor [4S-[4 alpha, 7 alpha, (R*), 12b beta]]-7-[S-(1-ethoxycarbonyl-3- phenylpropyl)amino]-1,2,3,4,6,7,8,12b-octahydro-6-oxo- pyrido[2,1-a][2]benzazepine-4-carboxylic acid in monkeys and dogs.
    Cheng H; Stuhler JD; Dorrbecker BR; Gordon WP
    Drug Metab Dispos; 1991; 19(1):212-7. PubMed ID: 1673401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-[N-((1S)-1-carboxy-3-phenyl-propyl)amino]propionyl)-1- methyl-2-oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs.
    Ikeo T; Yabana H; Kurosawa H; Kaburaki M; Kikkawa K; Narita H; Murata S; Yamaguchi I
    Arzneimittelforschung; 1992 Sep; 42(9):1109-14. PubMed ID: 1332727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of three metabolites of a new angiotensin-converting enzyme inhibitor, imidapril, in plasma and urine by gas chromatography-mass spectrometry using multiple ion detection.
    Matsuoka M; Horimoto S; Mabuchi M; Banno K
    J Chromatogr; 1992 Oct; 581(1):65-73. PubMed ID: 1430009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
    Okuyama Y; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats.
    Sasaki Y; Noguchi T; Seki J; Giddings JC; Yamamoto J
    Thromb Haemost; 2000 May; 83(5):722-7. PubMed ID: 10823269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Terashita S; Tokuma Y; Fujiwara T; Shiokawa Y; Okumura K; Noguchi H
    Xenobiotica; 1987 Dec; 17(12):1415-25. PubMed ID: 3439192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease.
    Zhang KE; Hee B; Lee CA; Liang B; Potts BC
    Drug Metab Dispos; 2001 May; 29(5):729-34. PubMed ID: 11302940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.